# Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization

> **NCT02218359** · PHASE2 · WITHDRAWN · sponsor: **Cardeas Pharma**

## Conditions studied

- Pneumonia, Bacterial

## Interventions

- **DRUG:** Amikacin Fosfomycin Inhalation Solution
- **DRUG:** Aerosolized placebo
- **DRUG:** Amikacin Fosfomycin Inhalation Solution

## Key facts

- **NCT ID:** NCT02218359
- **Lead sponsor:** Cardeas Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Participants Enrolled
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218359, "Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02218359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*